SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that it will report its unaudited financial results for the first quarter ended March 31, 2009 on Monday, May 11, 2009, after the U.S. financial markets close. ACADIA's management will host a conference call and webcast on Monday, May 11, 2009, at 5:00 p.m. Eastern Time to discuss ACADIA’s financial results and development programs.
